Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1037967

	registered interest
	date	08/01/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	CJD
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve diagnosis rates of sporadic Creutzfeldt-Jakob disease.
	tabling member constituency	Witham
	tabling member printed	Priti Patel
	uin	206318
	answer	answer is ministerial correction date of answer 16/01/2019 answer text <p>Early diagnosis of sporadic Creutzfeldt-Jakob Disease (sCJD) is challenging as the disorder is rare, and symptoms are non-specific, mimicking those seen in more common neurodegenerative, neuroinflammatory, and infectious disorders. Rapidity of progression and lack of response to treatment often leads clinicians to suspect a CJD diagnosis.</p><p> </p><p>The Department and the Scottish Government fund the National CJD Research and Surveillance Unit (NCJDRSU) to provide inter-disciplinary clinical and laboratory expertise (neurology, neuroradiology, neuropathology, biochemistry, and epidemiology) enabling early and accurate diagnosis of CJD. Clinicians from across the United Kingdom can discuss cases at any time. Highly trained specialists assess suspected cases locally within five days of referral and conduct structured assessments (clinical history, examination, and review of investigation results) before establishing diagnoses based on validated criteria. A consultant neuroradiologist at the NCJDRSU assesses neuroimaging for patients throughout the UK with a suspicion of CJD. The unit also provides a national diagnostic cerebrospinal fluid (CSF) 14-3-3/RT-QuIC service and will arrange collection of CSF samples with prompt results. Information on how clinicians can refer cases to the NCJDRSU is available at the following link:</p><p> </p><p><a href="http://www.cjd.ed.ac.uk/surveillance/referral-system" target="_blank">http://www.cjd.ed.ac.uk/surveillance/referral-system</a></p><p> </p><p>The Department and the Scottish Government have funded the development of diagnostic tests that combined with improved interpretation of neuroimaging has improved diagnostic accuracy.</p><p> </p><p>The NCJDRSU collects data on the number of people diagnosed with sCJD in the UK; break downs by of data for smaller geographies are not published. The following table shows a breakdown of the number of individuals, by year of death between 2014 and 2017. Date of diagnosis are considered synonymous for the purpose of reporting.</p><p> </p><p>Number of sCJD 2014-18 in the UK by year of death (as at January 2019).</p><table><tbody><tr><td><p>Year of death</p></td><td><p>Number</p></td></tr><tr><td><p>2014</p></td><td><p>99</p></td></tr><tr><td><p>2015</p></td><td><p>105</p></td></tr><tr><td><p>2016</p></td><td><p>119</p></td></tr><tr><td><p>2017</p></td><td><p>120</p></td></tr><tr><td><p>2018</p></td><td><p>125</p></td></tr></tbody></table><p>Source: NCJDRSU: <a href="https://www.cjd.ed.ac.uk/sites/default/files/figs.pdf" target="_blank">https://www.cjd.ed.ac.uk/sites/default/files/figs.pdf </a></p><p> </p><p>The NCJDRSU presents data regularly at clinical meetings and publishes in peer reviewed medical journals accessed by medical professionals, as well as producing a detailed annual report at the following link:</p><p> </p><p><a href="http://www.cjd.ed.ac.uk/sites/default/files/report26.pdf" target="_blank">http://www.cjd.ed.ac.uk/sites/default/files/report26.pdf</a></p><p> </p><p>The NCJDRSU website also provides information on the different types of CJD at the following link:</p><p> </p><p><a href="http://www.cjd.ed.ac.uk/surveillance/diagnosis-and-testing" target="_blank">http://www.cjd.ed.ac.uk/surveillance/diagnosis-and-testing</a></p><p> </p><p>sCJD is a rapidly progressive neurological disorder with an average time from first symptom onset to death of four months. The majority (88%) of individuals with sCJD over the past five years were assessed by clinicians from the NCJDRSU in life. After formal referral to NCJDRSU the average time to confirmation of the diagnosis was three days.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 206320 206323 206326 206327 question first answered 16/01/2019 15:05:48 answering member 4067 label Biography information for Steve Brine
	tabling member	4066 label Biography information for Priti Patel

1037969

	registered interest
	date	08/01/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	CJD
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that the symptoms of sporadic Creutzfeldt-Jakob disease are identified at the earliest opportunity.
	tabling member constituency	Witham
	tabling member printed	Priti Patel
	uin	206320
	answer	answer is ministerial correction date of answer 16/01/2019 answer text <p>Early diagnosis of sporadic Creutzfeldt-Jakob Disease (sCJD) is challenging as the disorder is rare, and symptoms are non-specific, mimicking those seen in more common neurodegenerative, neuroinflammatory, and infectious disorders. Rapidity of progression and lack of response to treatment often leads clinicians to suspect a CJD diagnosis.</p><p> </p><p>The Department and the Scottish Government fund the National CJD Research and Surveillance Unit (NCJDRSU) to provide inter-disciplinary clinical and laboratory expertise (neurology, neuroradiology, neuropathology, biochemistry, and epidemiology) enabling early and accurate diagnosis of CJD. Clinicians from across the United Kingdom can discuss cases at any time. Highly trained specialists assess suspected cases locally within five days of referral and conduct structured assessments (clinical history, examination, and review of investigation results) before establishing diagnoses based on validated criteria. A consultant neuroradiologist at the NCJDRSU assesses neuroimaging for patients throughout the UK with a suspicion of CJD. The unit also provides a national diagnostic cerebrospinal fluid (CSF) 14-3-3/RT-QuIC service and will arrange collection of CSF samples with prompt results. Information on how clinicians can refer cases to the NCJDRSU is available at the following link:</p><p> </p><p><a href="http://www.cjd.ed.ac.uk/surveillance/referral-system" target="_blank">http://www.cjd.ed.ac.uk/surveillance/referral-system</a></p><p> </p><p>The Department and the Scottish Government have funded the development of diagnostic tests that combined with improved interpretation of neuroimaging has improved diagnostic accuracy.</p><p> </p><p>The NCJDRSU collects data on the number of people diagnosed with sCJD in the UK; break downs by of data for smaller geographies are not published. The following table shows a breakdown of the number of individuals, by year of death between 2014 and 2017. Date of diagnosis are considered synonymous for the purpose of reporting.</p><p> </p><p>Number of sCJD 2014-18 in the UK by year of death (as at January 2019).</p><table><tbody><tr><td><p>Year of death</p></td><td><p>Number</p></td></tr><tr><td><p>2014</p></td><td><p>99</p></td></tr><tr><td><p>2015</p></td><td><p>105</p></td></tr><tr><td><p>2016</p></td><td><p>119</p></td></tr><tr><td><p>2017</p></td><td><p>120</p></td></tr><tr><td><p>2018</p></td><td><p>125</p></td></tr></tbody></table><p>Source: NCJDRSU: <a href="https://www.cjd.ed.ac.uk/sites/default/files/figs.pdf" target="_blank">https://www.cjd.ed.ac.uk/sites/default/files/figs.pdf </a></p><p> </p><p>The NCJDRSU presents data regularly at clinical meetings and publishes in peer reviewed medical journals accessed by medical professionals, as well as producing a detailed annual report at the following link:</p><p> </p><p><a href="http://www.cjd.ed.ac.uk/sites/default/files/report26.pdf" target="_blank">http://www.cjd.ed.ac.uk/sites/default/files/report26.pdf</a></p><p> </p><p>The NCJDRSU website also provides information on the different types of CJD at the following link:</p><p> </p><p><a href="http://www.cjd.ed.ac.uk/surveillance/diagnosis-and-testing" target="_blank">http://www.cjd.ed.ac.uk/surveillance/diagnosis-and-testing</a></p><p> </p><p>sCJD is a rapidly progressive neurological disorder with an average time from first symptom onset to death of four months. The majority (88%) of individuals with sCJD over the past five years were assessed by clinicians from the NCJDRSU in life. After formal referral to NCJDRSU the average time to confirmation of the diagnosis was three days.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 206318 206323 206326 206327 question first answered 16/01/2019 15:05:48 answering member 4067 label Biography information for Steve Brine
	tabling member	4066 label Biography information for Priti Patel

1037974

	registered interest
	date	08/01/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	CJD
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many people were diagnosed with sporadic Creutzfeldt-Jakob Disease in (a) Witham constituency, (b) the East of England and (c) England and Wales in the most recent five years for which data is available.
	tabling member constituency	Witham
	tabling member printed	Priti Patel
	uin	206323
	answer	answer is ministerial correction date of answer 16/01/2019 answer text <p>Early diagnosis of sporadic Creutzfeldt-Jakob Disease (sCJD) is challenging as the disorder is rare, and symptoms are non-specific, mimicking those seen in more common neurodegenerative, neuroinflammatory, and infectious disorders. Rapidity of progression and lack of response to treatment often leads clinicians to suspect a CJD diagnosis.</p><p> </p><p>The Department and the Scottish Government fund the National CJD Research and Surveillance Unit (NCJDRSU) to provide inter-disciplinary clinical and laboratory expertise (neurology, neuroradiology, neuropathology, biochemistry, and epidemiology) enabling early and accurate diagnosis of CJD. Clinicians from across the United Kingdom can discuss cases at any time. Highly trained specialists assess suspected cases locally within five days of referral and conduct structured assessments (clinical history, examination, and review of investigation results) before establishing diagnoses based on validated criteria. A consultant neuroradiologist at the NCJDRSU assesses neuroimaging for patients throughout the UK with a suspicion of CJD. The unit also provides a national diagnostic cerebrospinal fluid (CSF) 14-3-3/RT-QuIC service and will arrange collection of CSF samples with prompt results. Information on how clinicians can refer cases to the NCJDRSU is available at the following link:</p><p> </p><p><a href="http://www.cjd.ed.ac.uk/surveillance/referral-system" target="_blank">http://www.cjd.ed.ac.uk/surveillance/referral-system</a></p><p> </p><p>The Department and the Scottish Government have funded the development of diagnostic tests that combined with improved interpretation of neuroimaging has improved diagnostic accuracy.</p><p> </p><p>The NCJDRSU collects data on the number of people diagnosed with sCJD in the UK; break downs by of data for smaller geographies are not published. The following table shows a breakdown of the number of individuals, by year of death between 2014 and 2017. Date of diagnosis are considered synonymous for the purpose of reporting.</p><p> </p><p>Number of sCJD 2014-18 in the UK by year of death (as at January 2019).</p><table><tbody><tr><td><p>Year of death</p></td><td><p>Number</p></td></tr><tr><td><p>2014</p></td><td><p>99</p></td></tr><tr><td><p>2015</p></td><td><p>105</p></td></tr><tr><td><p>2016</p></td><td><p>119</p></td></tr><tr><td><p>2017</p></td><td><p>120</p></td></tr><tr><td><p>2018</p></td><td><p>125</p></td></tr></tbody></table><p>Source: NCJDRSU: <a href="https://www.cjd.ed.ac.uk/sites/default/files/figs.pdf" target="_blank">https://www.cjd.ed.ac.uk/sites/default/files/figs.pdf </a></p><p> </p><p>The NCJDRSU presents data regularly at clinical meetings and publishes in peer reviewed medical journals accessed by medical professionals, as well as producing a detailed annual report at the following link:</p><p> </p><p><a href="http://www.cjd.ed.ac.uk/sites/default/files/report26.pdf" target="_blank">http://www.cjd.ed.ac.uk/sites/default/files/report26.pdf</a></p><p> </p><p>The NCJDRSU website also provides information on the different types of CJD at the following link:</p><p> </p><p><a href="http://www.cjd.ed.ac.uk/surveillance/diagnosis-and-testing" target="_blank">http://www.cjd.ed.ac.uk/surveillance/diagnosis-and-testing</a></p><p> </p><p>sCJD is a rapidly progressive neurological disorder with an average time from first symptom onset to death of four months. The majority (88%) of individuals with sCJD over the past five years were assessed by clinicians from the NCJDRSU in life. After formal referral to NCJDRSU the average time to confirmation of the diagnosis was three days.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 206318 206320 206326 206327 question first answered 16/01/2019 15:05:48 answering member 4067 label Biography information for Steve Brine
	tabling member	4066 label Biography information for Priti Patel

1037977

	registered interest
	date	08/01/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	CJD
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department has taken to raise awareness among medical professionals of the symptoms of (a) sporadic, (b) variant, (c) genetic and (d) Iatrogenic Creutzfeldt-Jakob Disease.
	tabling member constituency	Witham
	tabling member printed	Priti Patel
	uin	206326
	answer	answer is ministerial correction date of answer 16/01/2019 answer text <p>Early diagnosis of sporadic Creutzfeldt-Jakob Disease (sCJD) is challenging as the disorder is rare, and symptoms are non-specific, mimicking those seen in more common neurodegenerative, neuroinflammatory, and infectious disorders. Rapidity of progression and lack of response to treatment often leads clinicians to suspect a CJD diagnosis.</p><p> </p><p>The Department and the Scottish Government fund the National CJD Research and Surveillance Unit (NCJDRSU) to provide inter-disciplinary clinical and laboratory expertise (neurology, neuroradiology, neuropathology, biochemistry, and epidemiology) enabling early and accurate diagnosis of CJD. Clinicians from across the United Kingdom can discuss cases at any time. Highly trained specialists assess suspected cases locally within five days of referral and conduct structured assessments (clinical history, examination, and review of investigation results) before establishing diagnoses based on validated criteria. A consultant neuroradiologist at the NCJDRSU assesses neuroimaging for patients throughout the UK with a suspicion of CJD. The unit also provides a national diagnostic cerebrospinal fluid (CSF) 14-3-3/RT-QuIC service and will arrange collection of CSF samples with prompt results. Information on how clinicians can refer cases to the NCJDRSU is available at the following link:</p><p> </p><p><a href="http://www.cjd.ed.ac.uk/surveillance/referral-system" target="_blank">http://www.cjd.ed.ac.uk/surveillance/referral-system</a></p><p> </p><p>The Department and the Scottish Government have funded the development of diagnostic tests that combined with improved interpretation of neuroimaging has improved diagnostic accuracy.</p><p> </p><p>The NCJDRSU collects data on the number of people diagnosed with sCJD in the UK; break downs by of data for smaller geographies are not published. The following table shows a breakdown of the number of individuals, by year of death between 2014 and 2017. Date of diagnosis are considered synonymous for the purpose of reporting.</p><p> </p><p>Number of sCJD 2014-18 in the UK by year of death (as at January 2019).</p><table><tbody><tr><td><p>Year of death</p></td><td><p>Number</p></td></tr><tr><td><p>2014</p></td><td><p>99</p></td></tr><tr><td><p>2015</p></td><td><p>105</p></td></tr><tr><td><p>2016</p></td><td><p>119</p></td></tr><tr><td><p>2017</p></td><td><p>120</p></td></tr><tr><td><p>2018</p></td><td><p>125</p></td></tr></tbody></table><p>Source: NCJDRSU: <a href="https://www.cjd.ed.ac.uk/sites/default/files/figs.pdf" target="_blank">https://www.cjd.ed.ac.uk/sites/default/files/figs.pdf </a></p><p> </p><p>The NCJDRSU presents data regularly at clinical meetings and publishes in peer reviewed medical journals accessed by medical professionals, as well as producing a detailed annual report at the following link:</p><p> </p><p><a href="http://www.cjd.ed.ac.uk/sites/default/files/report26.pdf" target="_blank">http://www.cjd.ed.ac.uk/sites/default/files/report26.pdf</a></p><p> </p><p>The NCJDRSU website also provides information on the different types of CJD at the following link:</p><p> </p><p><a href="http://www.cjd.ed.ac.uk/surveillance/diagnosis-and-testing" target="_blank">http://www.cjd.ed.ac.uk/surveillance/diagnosis-and-testing</a></p><p> </p><p>sCJD is a rapidly progressive neurological disorder with an average time from first symptom onset to death of four months. The majority (88%) of individuals with sCJD over the past five years were assessed by clinicians from the NCJDRSU in life. After formal referral to NCJDRSU the average time to confirmation of the diagnosis was three days.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 206318 206320 206323 206327 question first answered 16/01/2019 15:05:48 answering member 4067 label Biography information for Steve Brine
	tabling member	4066 label Biography information for Priti Patel

1038011

	registered interest
	date	08/01/2019
	answering body	Department for Transport
	answering dept id	27
	answering dept short name	Transport
	answering dept sort name	Transport
	hansard heading	A12
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Transport, what steps he is taking to progress the A12 Widening Scheme between Chelmsford and Marks Tey.
	tabling member constituency	Witham
	tabling member printed	Priti Patel
	uin	206342
	answer	answer is ministerial correction date of answer 16/01/2019 answer text <p>The Department for Transport and Highways England have been considering how best to take forward the A12 scheme, in the light of concerns raised by the Planning Inspector in June 2018 regarding the proposed Garden Community at Marks Tey and its interaction with the A12 scheme.</p><p>Highways England have been working closely with Essex County Council and the North Essex authorities to find the best approach to delivering the A12 scheme that takes account of wider growth in the region and achieves value for money. It is important that the Department find a way to take forward this important transport scheme while also supporting the Government’s objectives to improve the supply of housing where it is needed most.</p> answering member constituency Hereford and South Herefordshire answering member printed Jesse Norman question first answered 16/01/2019 13:54:02 answering member 3991 label Biography information for Jesse Norman
	tabling member	4066 label Biography information for Priti Patel

1038013

	registered interest
	date	08/01/2019
	answering body	Department for Transport
	answering dept id	27
	answering dept short name	Transport
	answering dept sort name	Transport
	hansard heading	A12
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Transport, what assessment he has made of the potential merits of widening the A12 north of Marks Tey.
	tabling member constituency	Witham
	tabling member printed	Priti Patel
	uin	206343
	answer	answer is ministerial correction date of answer 16/01/2019 answer text <p>As part of the current Road Investment Strategy, Highways England are developing a scheme to widen the A12 between Junctions 25 and 29. This will be considered against other strategic road priorities in the area as the Department make investment decisions. The Government expects to publish the second Road Investment Strategy in late 2019.</p> answering member constituency Hereford and South Herefordshire answering member printed Jesse Norman question first answered 16/01/2019 11:11:08 answering member 3991 label Biography information for Jesse Norman
	tabling member	4066 label Biography information for Priti Patel

1039613

	registered interest
	date	11/01/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Social Services: Disability
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure the forthcoming social care green paper will address social care provision for adults of working age with a disability.
	tabling member constituency	Vale of Clwyd
	tabling member printed	Chris Ruane
	uin	207569
	answer	answer is ministerial correction date of answer 16/01/2019 answer text <p>The Green Paper will cover care and support for adults of all ages, and incorporate insights from the joint work the Department of Health and Social Care has done with the Ministry of Housing, Communities and Local Government on working age adults with care and support needs.</p><p> </p><p>The joint work undertaken by the Department of Health and Social Care and the Ministry of Housing, Communities and Local Government last year engaged widely with stakeholders; including local authorities, providers, national charities and system partners as well as people with lived experience, family members and organisations run by disabled people such as DRUK and Inclusion London. Officials have also collated and reviewed existing reports and evidence previously produced by voluntary sector organisations and other partners as part of this work.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 16/01/2019 12:25:07 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	534 label Biography information for Chris Ruane

1039593

	registered interest
	date	11/01/2019
	answering body	Treasury
	answering dept id	14
	answering dept short name	Treasury
	answering dept sort name	Treasury
	hansard heading	Treasury: Brexit
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Chancellor of the Exchequer, how much money from the public purse has been (a) spent and (b) allocated for preparations for the UK leaving the EU without a deal to date; how much of that funding has been made by way of ministerial direction; and for what functions that funding has been allocated.
	tabling member constituency	Twickenham
	tabling member printed	Sir Vince Cable
	uin	207546
	answer	answer is ministerial correction date of answer 16/01/2019 answer text <p>HM Treasury has allocated over £4.2 billion of additional funding to departments and the Devolved Administrations for EU exit preparations so far. This breaks down as:</p><ul><li><p>£412m of additional funding over the spending review period for the Department for Exiting the European Union, Department for International Trade and the Foreign &amp; Commonwealth Office at Autumn Statement 2016.</p></li><li><p>£286m of additional funding for 17/18 (a full breakdown of which can be found in Supplementary Estimates 17/18: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/679738/PU2137_Supplementary_estimates_web.pdf.)</p></li><li><p>Over £1.5bn of additional funding for 18/19. A full breakdown of the allocations can be found in the Chief Secretary’s Written Ministerial Statement, HCWS540, laid on the 13th March (https://www.parliament.uk/business/publications/written-questions-answers-statements/written-statement/Commons/2018-03-13/HCWS540/)</p></li><li><p>Over £2bn of additional funding for 19/20. A full breakdown of the allocations can be found in the Chief Secretary’s Written Ministerial Statement, HCWS1205, laid on the 18th December (https://www.parliament.uk/business/publications/written-questions-answers-statements/written-statement/Commons/2018-12-18/HCWS1205/)</p></li></ul><p>This funding is in addition to departments efforts to reprioritise from business as usual toward preparations for the UK’s departure from the EU. As such, departments are best placed to provide an estimate of spend to date. HM Treasury requires departments to achieve value for money as part of receiving these additional funds, in line with the guidance set out in Managing Public Money. Two ministerial directions were made in relation to EU Exit in 2018 – by Defra and DfT. This is publicly available here researchbriefings.files.parliament.uk/documents/CBP-8412/CBP-8412.pdf. The Treasury does not centrally hold records for each direction, further information should be requested from the relevant departments.</p> answering member constituency South West Norfolk answering member printed Elizabeth Truss question first answered 16/01/2019 14:22:11 answering member 4097 label Biography information for Elizabeth Truss
	tabling member	207 label Biography information for Sir Vince Cable

1039594

	registered interest
	date	11/01/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Department of Health and Social Care: Brexit
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how much money his Department has allocated for preparations for the UK leaving the EU without a deal to date; how much of that funding has been made by way of ministerial direction; and for what functions that funding has been allocated.
	tabling member constituency	Twickenham
	tabling member printed	Sir Vince Cable
	uin	207547
	answer	answer is ministerial correction date of answer 16/01/2019 answer text <p>At Autumn Budget 2017, HM Treasury made an additional £3 billion of funding available over the next two years – £1.5 billion in each year – so that departments and the devolved administrations can continue to prepare effectively for European Union exit.</p><p> </p><p>That is in addition to the £700 million previously made available to prepare for EU exit at Autumn Budget 2016.</p><p> </p><p>In the Spring Statement on 13 March 2018, my Rt. hon. Friend the Chief Secretary to the Treasury (Elizabeth Truss MP) laid a Written Ministerial Statement, <a href="https://www.parliament.uk/business/publications/written-questions-answers-statements/written-statements/?page=1&amp;max=20&amp;questiontype=AllQuestions&amp;house=commons%2clords&amp;uin=HCWS540" target="_blank">HCWS540</a>, setting out the full Departmental allocations of the £1.5 billion for 2018/19.</p><p> </p><p>HM Treasury approved £21.1 million of funding for the Department of Health and Social Care’s preparations for EU exit in 2018/19, including planning for ‘no deal’. Spend against this allocation for 2018/19 will be included in the 2018/19 financial accounts in due course.</p><p> </p><p>The Autumn Budget 2018 confirmed an additional £500 million of cross-Government funding for 2019/20, meaning the Government will have invested over £4 billion in preparing for EU exit since 2016. This funding will help departments manage pressures and contingencies arising from EU exit preparations which fall in the 2019/20 financial year, as well as ensuring that the United Kingdom is prepared to seize the opportunities available when we leave the EU. The Department of Health and Social Care has been allocated £50 million from this budget, as set out in the Chief Secretary’s Written Ministerial Statement <a href="https://www.parliament.uk/business/publications/written-questions-answers-statements/written-statements/?page=1&amp;max=20&amp;questiontype=AllQuestions&amp;house=commons%2clords&amp;uin=HCWS1205" target="_blank">HCWS1205</a>, laid before Parliament on the 19 December 2018.</p><p> </p><p>No written ministerial direction for expenditure on contingency planning for ‘no deal’ has been sought by the Accounting Officer for the Department.</p><p> </p><p>The Department is preparing for all eventualities and the resources available to support preparations are kept under constant review.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 16/01/2019 12:40:06 answering member 1585 label Biography information for Stephen Hammond
	tabling member	207 label Biography information for Sir Vince Cable

1039595

	registered interest
	date	11/01/2019
	answering body	Northern Ireland Office
	answering dept id	21
	answering dept short name	Northern Ireland
	answering dept sort name	Northern Ireland
	hansard heading	Northern Ireland Office: Brexit
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Northern Ireland, how much money his Department has allocated for preparations for the UK leaving the EU without a deal to date; how much of that funding has been made by way of ministerial direction; and for what functions that funding has been allocated.
	tabling member constituency	Twickenham
	tabling member printed	Sir Vince Cable
	uin	207548
	answer	answer is ministerial correction date of answer 16/01/2019 answer text <p>EU Exit affects a number of work areas across the Department and will therefore encompass a proportion of workload for many staff, the amount of which will vary over time. Many of the same staff spend a proportion of their time preparing for leaving the EU (a) with and (b) without a deal. Those proportions vary continuously over time, so calculating a specific allocation would be disproportionately difficult.</p><p> </p> answering member constituency Weston-super-Mare answering member printed John Penrose question first answered 16/01/2019 12:40:50 answering member 1584 label Biography information for John Penrose
	tabling member	207 label Biography information for Sir Vince Cable